Table 3. Prevalence of the clinical NCD risk factors, the clustering of NCD risk factors and 10-year cardiovascular risk scores by nationality and gender (n = 4500).
| Variable | Gender | Nationalities | |||||
|---|---|---|---|---|---|---|---|
| Males 1996(44%) | Females 2504 (56%) | p value | Saudis 3062(68%) | ANS 1091(24%) | South Asian 309 (7%) | p value | |
| Body mass index sub-categories | |||||||
| Overweight | 783(39) | 783(31) | <0.001 | 980(32) | 427(39) | 137(44) | <0.001 |
| Obesity | 486(24) | 570(23) | 0.21 | 679(22) | 283(26) | 88(29) | <0.001 |
| Morbid obesity | 202(10) | 441(18) | <0.001 | 451(15) | 154(14) | 34(11) | <0.001 |
| Abdominal obesity | 1349(68) | 1323(53) | <0.001 | 1960(55) | 752(69) | 204(66) | <0.001 |
| Hypertension | |||||||
| Diagnosed | 484(24) | 496(20) | <0.001 | 613(20) | 256(24) | 99(32) | <0.001 |
| Undiagnosed | 37(2) | 18(1) | <0.001 | 39(1) | 11(1) | 4(1) | 0.76 |
| Abnormal glucose metabolism | |||||||
| Diabetes mellitus | 363(18) | 445(18) | 0.37 | 549(18) | 179(16) | 74(24) | 0.02 |
| prediabetes | 606(30) | 601(24) | <0.001 | 759(25) | 313(29) | 125(41) | <0.001 |
| Undiagnosed DM | 87(4) | 98(4) | 0.48 | 92(3) | 51(5) | 27(9) | 0.001 |
| Uncontrolled DM | 191(53) | 219(49) | <0.001 | 286(52) | 84(47) | 35(47) | <0.001 |
| Dyslipidaemia | |||||||
| Total cholesterol 656(37%) | 592(30) | 382(15) | <0.001 | 553(18) | 306(28) | 107(35) | <0.001 |
| Triglycerides, 974 (22%) | 743(37) | 913(37) | 0.31 | 1127(37) | 419(38) | 94(30) | 0.06 |
| LDL-C,1540 (34%) | 795(38) | 775(31) | <0.001 | 1036(34) | 395(36) | 95(31) | 0.26 |
| HDL-C, 1419 (32%) | 990(50) | 429(17) | <0.001 | 785(26) | 454(42) | 171(55) | <0.001 |
| Undiagnosed, 271 (6%) | 157(8) | 114(5) | <0.001 | 160(5) | 85(8) | 22(8) | 0.009 |
| Next 10 –year cardiovascular risk score | |||||||
| Low risk score < 10%: n = 2472(75%) | NA* | NA* | NA* | 1513(75) | 672(75) | 218(78) | 0.80 |
| Intermediate risk score 10–20%:n = 498 (15%) | NA* | NA* | NA* | 309(15) | 149(17) | 35(13) | 0.40 |
| High risk score >20%: n = 305 (10%) | NA* | NA* | NA* | 195(10) | 80(9) | 27(10) | 0.50 |
NA* not applicable; gender already included in risk score calculation. Data are showed as number of subjects (percentage).